IBM Retirement Fund reduced its position in Zoetis Inc (NYSE:ZTS) by 3.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,346 shares of the company’s stock after selling 291 shares during the quarter. IBM Retirement Fund’s holdings in Zoetis were worth $1,105,000 at the end of the most recent quarter.
Clarius Group LLC lifted its position in shares of Intel Co. (NASDAQ:INTC) by 3.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,126 shares of the chip maker’s stock after buying an additional 920 shares during the quarter. Clarius Group LLC’s holdings in Intel were worth $1,776,000 at the end of the most recent quarter.
Exane Derivatives cut its stake in shares of FMC Corp (NYSE:FMC) by 10.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 7,353 shares of the basic materials company’s stock after selling 878 shares during the period. Exane Derivatives’ holdings in FMC were worth $724,000 at the end of the most recent reporting period.
Chemed Co. (NYSE:CHE) Director Frank E. Wood sold 1,200 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $445.17, for a total value of $534,204.00. Following the transaction, the director now directly owns 1,457 shares in the company, valued at approximately $648,612.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Equities analysts predict that Alexandria Real Estate Equities Inc (NYSE:ARE) will post earnings per share (EPS) of $1.79 for the current quarter, according to Zacks. Zero analysts have issued estimates for Alexandria Real Estate Equities’ earnings, with the lowest EPS estimate coming in at $1.78 and the highest estimate coming in at $1.80. Alexandria Real Estate Equities posted earnings per share of $1.68 during the same quarter last year, which indicates a positive year over year growth rate of 6.5%. The firm is expected to announce its next quarterly earnings report after the market closes on Monday, February 3rd.
Tiffany & Co. (NYSE:TIF) – Equities research analysts at William Blair dropped their FY2020 earnings estimates for Tiffany & Co. in a research report issued on Thursday, December 26th, Zacks Investment Research reports. William Blair analyst D. Carden now forecasts that the specialty retailer will post earnings of $4.49 per share for the year, down from their prior estimate of $4.86. William Blair currently has a “Market Perform” rating on the stock. William Blair also issued estimates for Tiffany & Co.’s Q4 2020 earnings at $1.69 EPS, Q1 2021 earnings at $1.09 EPS, Q2 2021 earnings at $1.08 EPS, Q4 2021 earnings at $1.69 EPS and FY2021 earnings at $4.55 EPS.
Omega Healthcare Investors Inc (NYSE:OHI) – Analysts at Jefferies Financial Group dropped their FY2020 EPS estimates for shares of Omega Healthcare Investors in a report released on Thursday, January 16th. Jefferies Financial Group analyst J. Petersen now expects that the real estate investment trust will post earnings per share of $3.12 for the year, down from their prior estimate of $3.13.
Polaris Industries Inc. (NYSE:PII) – Analysts at Wedbush cut their Q4 2019 EPS estimates for Polaris Industries in a note issued to investors on Friday, January 17th. Wedbush analyst J. Hardiman now anticipates that the company will earn $1.75 per share for the quarter, down from their prior estimate of $1.81. Wedbush currently has a “Neutral” rating on the stock. Wedbush also issued estimates for Polaris Industries’ Q1 2020 earnings at $1.14 EPS and Q2 2020 earnings at $1.74 EPS.
EXACT Sciences Co. (NASDAQ:EXAS) – Stock analysts at Jefferies Financial Group boosted their FY2021 earnings per share estimates for shares of EXACT Sciences in a research note issued to investors on Thursday, January 9th, according to Zacks Investment Research. Jefferies Financial Group analyst B. Couillard now expects that the medical research company will post earnings per share of $0.69 for the year, up from their prior forecast of $0.68. Jefferies Financial Group currently has a “Buy” rating and a $120.00 target price on the stock.
IBI Group Inc (TSE:IBG) – Research analysts at Raymond James issued their Q4 2019 earnings estimates for IBI Group in a note issued to investors on Thursday, January 16th. Raymond James analyst F. Bastien forecasts that the company will post earnings of $0.13 per share for the quarter. Raymond James currently has a “Strong-Buy” rating and a $8.50 price objective on the stock. Raymond James also issued estimates for IBI Group’s Q1 2020 earnings at $0.14 EPS, Q2 2020 earnings at $0.18 EPS, Q3 2020 earnings at $0.19 EPS and Q4 2020 earnings at $0.14 EPS.